Antigen Test Could Identify Covid-19 Patients at Risk for Severe Illness
A study shows the Single Molecule Array (Simoa) SARS-CoV-2 antigen test could determine which covid-19 patients are most likely to become critically ill.
Read MorePosted by Melanie Hamilton-Basich | Sep 9, 2020 | Covid 19, Hematology & Serology |
A study shows the Single Molecule Array (Simoa) SARS-CoV-2 antigen test could determine which covid-19 patients are most likely to become critically ill.
Read MorePosted by Melanie Hamilton-Basich | Sep 9, 2020 | Covid 19, Hematology & Serology |
The BCC19 test kit utilizes portable laboratory-grade diagnostic technology that can run up to 96 tests per device in just 30 minutes.
Read MorePosted by Laurie Bonner | Sep 4, 2020 | Covid 19, Hematology & Serology |
The test is intended for the simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B.
Read MorePosted by Melanie Hamilton-Basich | Sep 4, 2020 | Covid 19, Hematology & Serology |
The panel consists of 14 units of a unique human plasma sample drawn from a single donor during a developing SARS-CoV-2 infection.
Read MorePosted by Melanie Hamilton-Basich | Sep 4, 2020 | Covid 19, Hematology & Serology |
ImmunoRank is designed to test up to 90 samples per test kit with 99.8% specificity for the detection of SARS-CoV-2 neutralizing antibodies in plasma.
Read More